… this study may contribute to improve antihypertensive therapy for a number of reasons. First,
the finding that combination therapy with enalapril and lercanidipine decreased 24-h BP by …

… This was a randomized, double-blind, placebo-controlled, four-way crossover study, …
primary efficacy variable since the mean 24-h BP is the most solid information provided by ABPM. …

Full article: Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in
daily practice. A comparison of office, self-measured and ambulatory blood pressure Skip to …

… of 354 randomized double-blind placebo-controlled trials of … with hypertension, as well as
in elderly and in diabetics. Puig … 4 was observed with the lercanidipine/enalapril combination …

… Our results are comparable to those seen in a study in elderly patients (age 60–85 years),
in which treatment with the combination of lercanidipine 10 mg plus enalapril 20 mg for 4 …

… The effective blood pressure decrease produced by the combination of the two active … a
placebo-controlled, randomised, four-fold cross-over study performed by Puig et al. with patients …

… hypertensive patients, including those with type 2 diabetes, lercanidipine/enalapril improved
BP … The fourth was a four-way crossover study (n = 62) comparing 4 weeks each of LER 10 …

… [BP] >140/90 mmHg) were eligible for this study. All patients received lercanidipine/enalapril…
each drug with respect to monotherapy, thus decreasing the risk of adverse eventsCitation4. …

… Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive
patients: placebo-controlled, randomized, crossover study with four ABPM. J. Hum. …

… in hypertensive patients treated with combination therapy … difference (approximately 4
mmHg) in systolic BP levels was … -blind, placebo-controlled, crossover clinical study on elderly …